{'fraction_non_alphanumeric': 0.046211714132187, 'fraction_numerical': 0.011821601289629231, 'mean_word_length': 5.1655629139072845, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 2, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Genetic restriction of immune responsiveness to synthetic peptides corresponding to sequences in the pre‐S region of the hepatitis B virus (HBV) envelope gene

Proteins of the HBV envelope (env) are coded for by two adjacent regions of the HBV env gene: the pre‐S and S regions. Antigenic determinants corresponding to amino acid sequences of both regions are recognized by human antibodies and are important in virus‐neutralizing responses. Protective immune responses to HBV appear to be linked to the major HLA histocompatibility complex. Inbred and congenic strains of mice represent a model system relevant for studies on the genetic control of immune responsiveness of humans to HBV envelope proteins. Such mouse strains were ranked according to their antibody response to the S protein and divided into high [d,q], intermediate [a,k,b], and low [s] responders (letters in brackets indicate H‐2 haplotype.) Selected pre‐S antigenic determinants can be mimicked with high fidelity by synthetic peptide analogues that are immunogenic without any carriers. Thus it is possible to study directly the genetic control of immune responsiveness to pre‐S epitopes mimicked by these peptides without having to consider the influence of carriers or of S protein. The results presented here show that inbred mouse strains can be ranked according to their antibody responses to the synthetic peptide pre‐S( 120–145) as follows: A/J[a] ≅ SWR/J[q] > C57BL/6J[b] ≅ AKR/J[k] ≅ SJL/J[s] ≫ DBA/2J[d] > BALB/ cJ[d]. Only SJL/J[s] mice responsed well to another synthetic peptide pre‐S (12‐ 32). Thus, H‐2‐linked genes regulating the immune response to S protein and to epitopes on pre‐S‐coded sequences are distinct. Anti‐pre‐S( 120‐ 145) responses in S protein‐nonresponders circumvent this nonresponsiveness. This should be considered in the design of hepatitis B vaccines.